Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

New autism treatment guidelines expand options for families

Carrie Friedman, NP
Conditions
November 22, 2025
Share
Tweet
Share

When the American Academy of Child and Adolescent Psychiatry released its October 2025 policy statement expanding what counts as valid, evidence-supported autism treatment, it marked a turning point that has been needed for years. For more than a decade, insurance companies pushed a narrow, outdated narrative that applied behavior analysis was the only evidence-based intervention for autism. That narrative was not accurate. It shaped policy, and it left families with little choice when ABA did not fit their child’s needs or values.

AACAP finally acknowledged the reality that clinicians, parents, and autistic adults have been saying for years. Autism is heterogeneous, and the evidence base includes far more than compliance-based ABA models.

The insurance myth that never held up in real life

Insurance companies long acted as if ABA was the single scientifically supported intervention. Anyone working with autistic children knew this was false. Developmental and relationship-based models such as DIR and Greenspan’s Floortime have had solid research foundations for years. Naturalistic developmental behavioral interventions, parent-mediated therapies, sensory-informed occupational therapy, and mental health interventions all belong in the evidence-based landscape.

Yet insurers refused to cover anything else. Families were cornered into ABA whether it suited their child’s neurology or not.

Listening to autistic adults: the harms many experienced

AACAP’s shift also reflects what autistic adults have been saying for decades. Many who grew up in older compliance-heavy ABA describe it as emotionally painful or even traumatic. Their accounts are consistent, widespread, and supported by peer-reviewed studies and large-scale surveys.

Adults report:

  • Being trained to comply over listening to their own body and emotions
  • Feeling punished for natural movement, communication, or stimming
  • Learning that authenticity was unacceptable while masking was praised
  • Developing chronic anxiety, low self-worth, or trauma symptoms

Not every ABA provider practices this way. Not every ABA program is harmful. But these lived experiences are genuine data. Ignoring them has never been ethical.

My family chose a different path when insurance refused to offer options

When my own autistic children were toddlers, I faced the same rigid system. ABA was the only thing insurance would cover. Floortime was not available in my area. It was not reimbursed, and yet it was the approach that aligned with the developmental science and with my children’s emotional needs.

So I learned it myself.

I studied Stanley Greenspan’s DIR/Floortime model and became, in many ways, my children’s primary developmental therapist. I used the model daily, building long, connected, playful interactions rooted in their interests and sensory profile. We were not extinguishing their natural traits. We were meeting them in their world and inviting them into reciprocity, imagination, and emotional understanding.

Floortime changed everything for us.

What it meant in practice

ADVERTISEMENT

  • Connection was the core engine
  • Their special interests became the entry point for engagement
  • Agency and autonomy were respected
  • Emotional communication was the goal, not performance
  • Social interaction became intrinsically meaningful rather than a token reward

The impact was profound. Neither of my children spoke at age three. Eye contact was fleeting. Their sensory and emotional regulation were fragile. Through Floortime, both developed language, emotional literacy, deep reciprocity, and the ability to form genuine relationships. Today at 10 and 12 they are mainstreamed, socially engaged, emotionally aware, and able to regulate through challenges using a wide range of internal and behavioral tools, including adapted DBT strategies.

We did utilize ABA therapies but later. At ages six and eight they entered a Montessori-informed ABA program that respected their autonomy and blended well with their developmental foundation and ages. That was a positive experience because the philosophy fit them. And that is the larger point.

Autism is not one thing. Treatment should never be one thing.

AACAP finally says what families knew all along

AACAP’s October statement affirms a truth that should always have guided care. There is no single correct treatment for autism. There is no universal formula. There is no ethical basis for funneling every autistic child into one model.

Insurance companies relied on outdated talking points for years. Families paid the price.

Real informed consent requires real options.

Informed consent cannot exist when families are told that ABA is the only evidence-based treatment simply because it is the only one insurance will pay for. Families deserve accurate information, which includes the fact that developmental, sensory-informed, and relationship-based models have long-standing scientific support.

Clinicians deserve the freedom to practice evidence-based medicine without reimbursement politics shaping the treatment plan.

Children deserve therapeutic approaches that respect their neurology, humanity, and autonomy.

Insurance is now out of excuses.

With AACAP’s updated guidance, insurers no longer have a scientific justification for denying coverage of developmental and relationship-based therapies. Continuing to reimburse only ABA is not a policy decision rooted in evidence. It is a business decision that contradicts national clinical standards.

Families should not have to become their child’s therapist because no covered alternative exists. My decision to learn and implement Greenspan’s Floortime changed my children’s lives, but it should never have been the only way to access a developmental approach. I was fortunate that I was able to stop working for two years to be able to provide my children’s care. Not every family has that option.

A more honest era of autism care can begin now

AACAP’s policy update is not revolutionary. It is a long overdue alignment with reality. The next step is accountability. Insurers must expand coverage. Clinicians must present families with accurate options. And systems must finally recognize that the diversity of autistic children requires a diversity of evidence-based interventions.

Autistic children and their families deserve nothing less.

Carrie Friedman is a dual board-certified psychiatric and family nurse practitioner and the founder of Brain Garden Psychiatry in California. She integrates evidence-based psychopharmacology with functional and integrative psychiatry, emphasizing root-cause approaches that connect neuro-nutrition and gut–brain science, metabolic psychiatry, immunology, endocrinology, and mind–body lifestyle medicine. Carrie’s clinical focus bridges conventional psychiatry with holistic strategies to support mental health through nutrition, physiology, and sustainable lifestyle interventions. Her professional writing explores topics such as functional medicine, autism, provider well-being, and medical ethics.

Prev

Why visitor bans hurt patient care

November 22, 2025 Kevin 0
…

Kevin

Tagged as: Pediatrics

Post navigation

< Previous Post
Why visitor bans hurt patient care

ADVERTISEMENT

More by Carrie Friedman, NP

  • Rethinking stimulants for ADHD

    Carrie Friedman, NP
  • A nurse practitioner on leaving the medical machine

    Carrie Friedman, NP
  • The ethics of marketing unproven autism tests

    Carrie Friedman, NP

Related Posts

  • A game-changer in methamphetamine treatment

    Roneet Lev, MD
  • Families come in various forms

    Emily S. Hagen, MD
  • Why we need to expand Medicaid

    Mona Bascetta
  • How to avoid treatment you don’t need

    Marshall Allen
  • The false link between Tylenol and autism

    Anonymous
  • For treatment, please call Dr. Congressman

    Joseph Lanctot, FNP-C

More in Conditions

  • Is white coat hypertension harmless?

    Monzur Morshed, MD and Kaysan Morshed
  • Gen Z, ADHD, and divided attention in therapy

    Ronke Lawal
  • Early-onset breast cancer: a survivor’s story

    Sara Rands
  • Remote second opinions for equitable cancer care

    Yousuf Zafar, MD
  • Why psychiatrists can’t treat family members

    Farid Sabet-Sharghi, MD
  • Aging parents and Thanksgiving: a gentle check-in

    Barbara Sparacino, MD
  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
    • New autism treatment guidelines expand options for families

      Carrie Friedman, NP | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • New autism treatment guidelines expand options for families

      Carrie Friedman, NP | Conditions
    • Why visitor bans hurt patient care

      Emmanuel Chilengwe | Education
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is trauma surgery a dying field?

      Farshad Farnejad, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
    • New autism treatment guidelines expand options for families

      Carrie Friedman, NP | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • New autism treatment guidelines expand options for families

      Carrie Friedman, NP | Conditions
    • Why visitor bans hurt patient care

      Emmanuel Chilengwe | Education
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is trauma surgery a dying field?

      Farshad Farnejad, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...